Cervical Cancer

Cervical Cancer

Cervical cancer is unique among common cancers: it has a single, known cause – the human papillomavirus (HPV) – and highly effective screening and prevention tools have the potential to virtually eliminate deaths from the disease. Research into HPV and cervical cancer detection has helped to reduce U.S. cervical cancer death rates by nearly 70 percent since the 1950s.

Despite these advances, nearly 12,000 American women are still diagnosed with cervical cancer annually, primarily because they do not receive routine screening and follow-up care. Moreover, with limited access to vaccines, screening, and treatment in low resource countries, annual mortality is 250,000 worldwide.

While screening and vaccination remain the first lines of defense, researchers are also working to improve treatments for women diagnosed with cervical cancer. 

Expand All +

1943

Doctors begin routine Pap testing

Doctors begin routine Pap testing

The Pap test is first introduced into physician's offices, enabling doctors to detect and begin treating cervical cancer before it has a chance to spread. Over the following decades, the Pap test is credited with driving down cervical cancer death rates in the U.S. and other wealthy countries. Yet cervical cancer remains a major cause of death in low-resource settings around the world, where access to screening and treatment is limited.

1928

Discovery lays groundwork for development of the Pap test, the first-ever cancer screening test

Discovery lays groundwork for development of the Pap test, the first-ever cancer screening test

George Papanicolaou discovers that vaginal cell smears can reveal the presence of cervical cancer. This finding paves the way for the development of the first effective cancer screening test over the next 15 years. With refinements over the following decades, the Papanicolaou test (or Pap test, or Pap smear) remains the gold standard for cervical cancer screening and has been credited with reducing cervical cancer deaths by 70 percent in the U.S.

1905

Radical hysterectomy used to treat early cervical cancers

Radical hysterectomy used to treat early cervical cancers

British surgeon Ernst Wertheim introduces a new surgical technique, the 'Wertheim radical hysterectomy,' reporting that more than 30 percent of cervical cancer patients who underwent the surgery remained free of cancer after five years. This result is considered a monumental feat for the time, despite the fact that about 15 percent of women died during the procedure. The surgery, which involves the removal of the uterus, cervix and surrounding lymph nodes through an abdominal incision, soon becomes the standard treatment for uterine and cervical cancers. Over the following decades, however, it is refined to dramatically reduce the risk of complications, improve outcomes and leave more healthy tissue intact. The highly refined approach is still used today for patients with early-stage cervical cancer.